Chemical Development, Boehringer-Ingelheim Pharmaceuticals Inc. 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877-0368 (USA).
Research and Development, Boehringer Ingelheim (Canada) Ltd. 2100 Cunard Street, Laval, Québec H7S 2G5 (Canada).
Angew Chem Int Ed Engl. 2015 Jun 8;54(24):7144-8. doi: 10.1002/anie.201501575. Epub 2015 May 4.
A practical and efficient synthesis of a complex chiral atropisomeric HIV integrase inhibitor has been accomplished. The combination of a copper-catalyzed acylation along with the implementation of the BI-DIME ligands for a ligand-controlled Suzuki cross-coupling and an unprecedented bis(trifluoromethane)sulfonamide-catalyzed tert-butylation renders the synthesis of this complex molecule robust, safe, and economical. Furthermore, the overall synthesis was conducted in an asymmetric and diastereoselective fashion with respect to the imbedded atropisomer.
已完成一种复杂的手性对映异构 HIV 整合酶抑制剂的实用且高效的合成。铜催化酰化与 BI-DIME 配体的结合用于配体控制的铃木交叉偶联,以及前所未有的双(三氟甲烷)磺酰胺催化叔丁基化,使这种复杂分子的合成具有稳健、安全和经济的特点。此外,整个合成过程是不对称的,并且对于嵌入的对映异构体具有非对映选择性。